RZG - ETF AI Analysis
Top Page
Invesco S&P Smallcap 600 Pure Growth ETF (RZG)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid momentum in its small-cap growth strategy.
Top Holdings Showing Strong Growth
Many of the largest positions, such as ACM Research, Powell Industries, and Liquidia Technologies, have posted strong year-to-date performance, helping drive the fund’s returns.
Broad Sector Diversification
Holdings spread across health care, technology, financials, industrials, and several other sectors help reduce the impact if any one industry runs into trouble.
Negative Factors
Higher Expense Ratio for a Passive ETF
The fund’s expense ratio is on the higher side for an index-based ETF, which means more of your returns go toward fees over time.
Concentration in U.S. Market Only
With essentially all assets invested in U.S. companies, the ETF offers no geographic diversification and is fully exposed to the U.S. economic cycle.
Heavy Tilt Toward Small-Cap Growth
Because the fund focuses on smaller, fast-growing companies, its share price can be more volatile and sensitive to changes in investor sentiment than broader market funds.
RZG vs. SPDR S&P 500 ETF (SPY)
AUM120.97M
RegionNorth America
Expense Ratio0.35%
Beta0.96
IssuerInvesco
Inception DateMar 01, 2006
Dividend Yield0.57%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Pure Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,826
30 Day Avg. Volume10,986
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
84.84Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering126
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RZG Summary
The Invesco S&P SmallCap 600 Pure Growth ETF (RZG) follows the S&P SmallCap 600 Pure Growth Index, focusing on fast-growing smaller U.S. companies. It holds a mix of health care, technology, financial, and industrial stocks, including names like ACM Research and Clear Secure. Someone might invest in RZG to seek higher growth by backing smaller, more agile businesses and to diversify beyond large, well-known companies. However, because it focuses on small growth stocks, its price can be more volatile and can go up and down sharply with changes in the market.
How much will it cost me?The Invesco S&P SmallCap 600 Pure Growth ETF (RZG) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average because it is designed to track a specific niche index of small-cap growth companies, requiring more active management. It’s a good option if you’re looking for targeted exposure to high-growth small-cap stocks.
What would affect this ETF?The ETF's focus on U.S. small-cap growth companies means it could benefit from economic expansion, increased innovation, and favorable conditions for entrepreneurial businesses, particularly in sectors like health care and technology. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, or economic slowdowns that disproportionately impact small-cap stocks. Regulatory changes in key sectors like health care or financials could also influence performance.
RZG Top 10 Holdings
RZG is powered by a pack of fast-moving U.S. small caps, with health care and industrial names setting the tone. Liquidia Technologies and ACM Research have been rising over the year, giving the fund much of its growth punch, even if their recent trading has been a bit mixed. DXP Enterprises and Powell Industries add steady industrial strength, though their momentum has cooled lately. On the flip side, Dave and StoneX Group have been lagging in the short term, occasionally acting like a brake on an otherwise growth-focused, domestically concentrated portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ACM Research | 2.76% | $3.30M | $5.81B | 100.62% | 72 Outperform | |
| Acadian Asset Management | 2.01% | $2.40M | $3.34B | 103.65% | 66 Neutral | |
| Protagonist Therapeutics | 1.99% | $2.38M | $9.06B | 116.04% | 68 Neutral | |
| Dave | 1.87% | $2.23M | $4.42B | 70.36% | 80 Outperform | |
| The Chefs' Warehouse | 1.76% | $2.10M | $4.75B | 109.99% | 72 Outperform | |
| DXP Enterprises | 1.68% | $2.00M | $3.01B | 52.78% | 71 Outperform | |
| Arcutis Biotherapeutics | 1.64% | $1.95M | $3.16B | 26.30% | 60 Neutral | |
| StoneX Group | 1.52% | $1.81M | $7.94B | 46.53% | 58 Neutral | |
| Powell Industries | 1.51% | $1.80M | $7.14B | 93.48% | 76 Outperform | |
| Solaris Energy Infrastructure | 1.38% | $1.65M | $6.01B | 67.85% | 69 Neutral |
RZG Technical Analysis
Neutral
―
Price Trends
66.81
Negative
67.14
Negative
62.84
Positive
Market Momentum
-1.09
Negative
39.03
Neutral
42.68
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RZG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 64.02, equal to the 50-day MA of 66.81, and equal to the 200-day MA of 62.84, indicating a neutral trend. The MACD of -1.09 indicates Negative momentum. The RSI at 39.03 is Neutral, neither overbought nor oversold. The STOCH value of 42.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RZG.
RZG Peer Comparison
Comparison Results
Performance Comparison
RZG
Invesco S&P Smallcap 600 Pure Growth ETF
63.44
9.28
17.13%
ISCG
iShares Morningstar Small-Cap Growth ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JSML
Janus Henderson Small Cap Growth Alpha ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents